Bindinglaw

US · guidance

CMS SOM App. C, Tag D2075

§493.837 Standard: General immunology

activein force · 2026-07-22 – presentas-observed

Refer to Subpart I for analytes or tests for which laboratory PT performance is to be

evaluated.

NOTE: If a laboratory performs both a quantitative and a qualitative procedure of a test

or analyte, it may choose which to enroll in to fulfill the enrollment requirement. It need

not enroll in both quantitative and qualitative PT for the same analyte. The laboratory is

required to perform twice a year verification of accuracy for the test not enrolled for PT.

(See §493.1236/D5217)

(a) Failure to attain a score of at least 80 percent of acceptable responses for each

analyte in each testing event is unsatisfactory analyte performance for the testing

event.

History

Rev. 233; Issued: 09-12-25; Effective: 09-12-25; Implementation: 09-12-25

Provenance

Source
cms.gov
Retrieved
2026-07-22
Edition
som-2026-07-22
Content hash
2970dc55f8f53736e593582bd27ed0674c3ba7abdf88347ac6f399de3626ac8d
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.